← FDA DRUG APPROVALS

FDA ANDA · ANDA209408

CEFEPIME

Sponsor: SAMSON MEDCL

APPLICATION
ANDA209408
TYPE
ANDA
ORIGINAL APPROVAL
2018-08-21
LATEST ACTION
2018-08-21
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription

Products

CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINERPrescription
CEFEPIME HYDROCHLORIDE EQ 100GM BASE · POWDER · INTRAVENOUS

Approval history

2018-08-21UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →